Rtw Investments, LP Cytom X Therapeutics, Inc. Transaction History

Rtw Investments, LP

$6.51 Billion
Q2 2025

A detailed history of Rtw Investments, LP transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 3,461,500 shares of CTMX stock, worth $11 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

3,461,500

Holding current value

$11 Million

% of portfolio

0.12%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$0.43 - $2.99 $1.49 Million - $10.3 Million	3,461,500 New	3,461,500 $7.86 Million
Q2 2024 Aug 14, 2024	BUY	$1.21 - $5.13 $1.45 Million - $6.16 Million	1,200,002 New	1,200,002 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$1.53 - $2.89 $4.48 Million - $8.47 Million	-2,929,993 Reduced 50.69%	2,849,707 $5.22 Million
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $667,500 - $1.17 Million	-250,000 Reduced 4.15%	5,779,700 $15.4 Million
Q4 2021 Feb 14, 2022	BUY	$3.87 - $7.39 $17.9 Million - $34.2 Million	4,628,761 Added 330.4%	6,029,700 $26.1 Million
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $840,744 - $1.32 Million	-132,819 Reduced 8.66%	1,400,939 $8.87 Million
Q1 2021 May 14, 2021	BUY	$6.6 - $9.0 $42,279 - $57,654	6,406 Added 0.42%	1,533,758 $11.9 Million
Q4 2020 Feb 16, 2021	BUY	$6.47 - $7.9 $8,728 - $10,657	1,349 Added 0.09%	1,527,352 $10 Million
Q3 2020 Nov 16, 2020	BUY	$6.55 - $8.83 $75,501 - $101,783	11,527 Added 0.76%	1,526,003 $10.1 Million
Q2 2020 Aug 14, 2020	BUY	$7.4 - $14.64 $3.31 Million - $6.55 Million	447,685 Added 41.97%	1,514,476 $12.6 Million
Q1 2020 May 15, 2020	BUY	$3.61 - $8.6 $98,184 - $233,902	27,198 Added 2.62%	1,066,791 $8.18 Million
Q4 2019 Feb 14, 2020	BUY	$5.17 - $8.91 $254,002 - $437,748	49,130 Added 4.96%	1,039,593 $8.64 Million
Q3 2019 Nov 14, 2019	BUY	$7.38 - $12.25 $15,822 - $26,264	2,144 Added 0.22%	990,463 $7.31 Million
Q2 2019 Aug 14, 2019	BUY	$9.35 - $11.41 $215,676 - $263,194	23,067 Added 2.39%	988,319 $11.1 Million
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $538,327 - $1.09 Million	56,666 Added 6.24%	965,252 $10.4 Million
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $11.5 Million - $16.9 Million	908,586 New	908,586 $13.7 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

123M

Call Options Held

305K

Put Options Held

121K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $210M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.

Account

Rtw Investments, LP Cytom X Therapeutics, Inc. Transaction History